 02 Company Overview 
Advanced Medical Solutions Group plc  Annual Report 2014
At a Glance
Branded 
Distributed
Sales of AMS Group brands: 
LiquiBand® and RESORBA®, 
through our global network 
of distributors.
Branded  
Direct
Direct sales of AMS Group 
brands: ActivHeal®, 
LiquiBand® and RESORBA®, 
through our own sales teams 
in Germany, UK and Czech 
Republic.
The Group operates through four Business Units which are each responsible for 
their respective sales, marketing and Research and Development (R&D) activities. 
Each Business Unit focuses on a different strategic route to market.
OEM
Sales of finished  
products to 
our OEM partners.
Bulk 
Materials
Sales of bulk materials  
to converters and  
healthcare companies.
Our Business Units
More on  
page 13
More on  
page 14
More on  
page 15
More on  
page 16 Financial Statements Governance Strategic Report Company Overview
Advanced Medical Solutions Group plc  Annual Report 2014
03
The Group is involved in the design, development, manufacture and distribution 
of novel, high performance materials for use in advanced woundcare products 
and surgical dressings as well as medical adhesives and sutures for closing and 
sealing tissue.
AMS Products and Markets
SILVER
ALGINATES
FOAM
R&D
NEW
TECHNOLOGIES
TOPICAL
ADHESIVES
SUTURES
INTERNAL 
ADHESIVES
HAEMOSTATS
Surgical
ALGINATES
Advanced  
Woundcare
Surgical market:
• Market size $7bn – growing 
approximately 4–5% per 
annum
• Sutures – 45% of total market
• Tissue adhesives – growing 
at 8% per annum
• US – dominant market for 
tissue adhesives
Advanced woundcare market:
• Global advanced woundcare 
market $3.2bn – growing at 
2-3% per annum
• Focus on moist wound 
healing – faster, less pain and 
scarring
• Treatment of chronic wounds 
(e.g. ulcers, pressure sores) – 
link to diabetes and obesity
